Market Cap
$11.3B
SNN
SMITH & NEPHEW PLC
$26.42 ▼ -0.60%
Prev close $26.58Market cap$11.3B
ConsensusHold
12-mo target$32.72 (+23.9%)
▲ Neutral
Analyst conviction 5/10
38 New Institutional Positions10 Institutional Exits Healthcare & Medical Devices
Snapshot
The big-picture read on SNN right now — valuation, ownership and activity at a glance.
Cap Size
Large Cap
Analyst Consensus
Hold (46%)
Inst. Holders
50 funds
Inst. Value
$743.0M
Inst. Activity
38 buys / 10 sells
SEC Reports
20
Press Releases
3
Price chart 30d -7.9%
Daily candles (open–high–low–close) with volume. Green = up day, red = down day.
No data for this timeframe.
Vol
Recent activity
The latest filings, insider trades, analyst actions, press and options flow — newest first.
Sep 24, 2026 short_volume
Sep 16, 2026 SEC Short Volume: SNN — 63.5% short (0.3M / 0.5M)
Short: 334,160 | Exempt: 499 | TRF Vol: 526,250 | Short Ratio: 63.5% | Off-exchange volume (dark poo
Smith & Nephew completed its cash tender offer for up to $250M of its 2.032% Senior Notes due 2030, accepting $250M of t
6-K — Impact 3/10
Smith & Nephew priced its cash tender offer to purchase up to $250 million of its 2.032% Senior Notes due 2030 (out of $
6-K — Impact 3/10
Smith & Nephew filed a 6-K to finalize the issuance of $700M in 5.750% senior unsecured notes due 2036, executed via a F
6-K — Impact 4/10
Smith+Nephew received FDA De Novo classification for its TESSA Spatial Surgery System, creating a new regulatory categor
Impact 6/10
Jun 30, 2026 Inst.
BRANDES INVESTMENT PARTNERS, LP — ADD
2,148,731 shares ($61.9M)
Jun 30, 2026 Inst.
Jun 1, 2026 Press DIMENSIONAL FUND ADVISORS LP — ADD
1,837,261 shares ($53.1M)
Smith+Nephew announced the US launch of the next-generation LEAF Patient Monitoring System, a cloud-based platform using
Impact 5/10
Analyst ratings buy % -14.8%
How Wall Street rates the stock today, and the latest firm-by-firm actions.
46% rate it Buy or better · 24 analysts
Recent analyst actions
| Date | Firm | Action | Rating | Firm rating |
|---|---|---|---|---|
| Aug 31, 2026 | BTIG | INITIATE | Neutral | 53% |
| Aug 6, 2026 | JP Morgan | DOWNGRADE | Neutral | 55% |
| Aug 5, 2026 | Barclays | DOWNGRADE | Underweight | 54% |
| May 11, 2026 | Canaccord Genuity | MAINTAIN | Hold | 47% |
Monthly consensus history
| Period | Str. Buy | Buy | Hold | Sell | Str. Sell | Buy % | Distribution |
|---|---|---|---|---|---|---|---|
| Sep 1, 2026 | 5 | 6 | 12 | 1 | 0 | 46% | |
| Aug 1, 2026 | 5 | 7 | 12 | 0 | 0 | 50% | |
| Jul 1, 2026 | 5 | 7 | 12 | 0 | 0 | 50% | |
| Jun 1, 2026 | 6 | 7 | 11 | 0 | 0 | 54% | |
| May 1, 2026 | 6 | 7 | 11 | 0 | 0 | 54% | |
| Apr 1, 2026 | 6 | 6 | 11 | 1 | 0 | 50% | |
| Mar 1, 2026 | 7 | 6 | 10 | 1 | 0 | 54% | |
| Feb 1, 2026 | 7 | 7 | 10 | 0 | 0 | 58% |
Price targets
Where 5 covering analysts think SNN trades over the next 12 months.
$32.72 +23.9% upside Strong Buy
Current$26.42 Low$30.00 Median$31.55 High$38.00 5 analysts
$30.00$38.00
Analyst rating Hold· 2.8/5 as of Oct 2, 2026
Reports & filings
AI-scored summaries of recent SEC filings and press releases, with sentiment and impact.
20 SEC filing reports analyzed · 2 bullish, 2 bearish, 1 mixed, 15 neutral · avg impact 3.6/10.Plus 3 press releases.
NEUTRAL6-K3/10
Smith & Nephew completed its cash tender offer for up to $250M of its 2.032% Senior Notes due 2030,
Sep 16, 2026
NEUTRAL6-K3/10
Smith & Nephew priced its cash tender offer to purchase up to $250 million of its 2.032% Senior Note
Sep 16, 2026
NEUTRAL6-K4/10
Smith & Nephew filed a 6-K to finalize the issuance of $700M in 5.750% senior unsecured notes due 20
Sep 11, 2026
NEUTRAL6-K4/10
Smith & Nephew priced $700M of 5.750% Notes due 2036, receiving net proceeds of ~$690.9M. The funds
Sep 10, 2026
Upcoming & catalyst events
Scheduled dates plus disclosed catalysts — earnings, dividends, enforcement, FDA and clinical-trial events. Colored dot = impact.
Sep 24, 2026
short_volume
Short Volume: SNN — 63.5% short (0.3M / 0.5M)
Short: 334,160 | Exempt: 499 | TRF Vol: 526,250 | Short Ratio: 63.5% | Off-exchange volume (dark pool + OTC)
Sep 23, 2026
announcement
MULTIMEDIA UPDATE: Smith+Nephew launches the new EVOS™ PELVIC Plating System at the 2026 Orthopedic Trauma Association (OTA) Annual Meeting, expanding the EVOS Plating Platform for pelvic and acetabular fracture management
Smith+Nephew launches the new EVOS PELVIC Plating System at the 2026 Orthopedic Trauma Association (OTA) Annual Meeting
Sep 23, 2026
announcement
Smith+Nephew launches the new EVOS™ PELVIC Plating System at the 2026 Orthopedic Trauma Association (OTA) Annual Meeting, expanding the EVOS Plating Platform for pelvic and acetabular fracture management
Smith+Nephew launches the new EVOS PELVIC Plating System at the 2026 Orthopedic Trauma Association (OTA) Annual Meeting
Sep 23, 2026
short_volume
Short Volume: SNN — 63.3% short (0.4M / 0.6M)
Short: 351,366 | Exempt: 951 | TRF Vol: 555,257 | Short Ratio: 63.3% | Off-exchange volume (dark pool + OTC)
Sep 21, 2026
other
Smith+Nephew to showcase leading shoulder technologies for joint repair and reconstruction at ICSES 2026
Smith+Nephew to showcase leading shoulder technologies for joint repair and reconstruction at ICSES 2026
Earnings estimates
Forecast earnings per share and revenue by period — and whether estimates are rising.
| Period | EPS Est. | Range | Growth | 30d Rev | Up/Dn | Revenue | # |
|---|---|---|---|---|---|---|---|
| Current Q | $0.53 | $0.53–$0.53 | — | — | — | $1.6B | 1 |
| Next Q | $0.71 | $0.71–$0.71 | — | — | — | $1.8B | 1 |
| Current FY | $2.22 | $2.19–$2.27 | 9.0% | +2.0% | — | $6.5B | 4 |
| Next FY | $2.41 | $2.32–$2.50 | 8.4% | -0.7% | 0↑ 1↓ | $6.8B | 4 |
Current-quarter EPS estimate — revision history
| When | EPS estimate | Change vs now |
|---|---|---|
| Current | $0.530 | — |
| 7d ago | $0.000 | +0.530 |
| 30d ago | $0.000 | +0.530 |
| 60d ago | $0.000 | +0.530 |
| 90d ago | $0.000 | +0.530 |
Institutional ownership
Which big funds own SNN (from quarterly 13F filings) and who is adding or trimming.
50 institutional holders with $743.0M total value (25,763,426 shares) as of 2026-Q2. Top holders: Clear, NOMURA, GOLDMAN. Net buying activity: 38 institutions added/increased vs 10 reduced.
Top holders — 2026-Q2
| Fund | Shares | Value | % Tracked | Last move |
|---|---|---|---|---|
| Clear Street Group Inc. | 2,560 | $0.00 | 0.0% | — |
| NOMURA ASSET MANAGEMENT CO LTD | 0 | $0.00 | 0.0% | — |
| GOLDMAN SACHS GROUP INC | 3,069,598 | $88.4M | 11.9% | — |
| BRANDES INVESTMENT PARTNERS, LP | 2,148,731 | $61.9M | 8.3% | ADD +60.1% |
| DIMENSIONAL FUND ADVISORS LP | 1,837,261 | $53.1M | 7.2% | ADD +74.5% |
| LMR Partners LLP | 1,767,872 | $50.9M | 6.9% | NEW |
| CAUSEWAY CAPITAL MANAGEMENT LLC | 1,565,167 | $45.1M | 6.1% | ADD +64.2% |
| WELLS FARGO & COMPANY/MN | 1,375,531 | $39.6M | 5.3% | DOUBLED +165.7% |
| MORGAN STANLEY | 1,204,463 | $34.7M | 4.7% | — |
| BANK OF MONTREAL /CAN/ | 1,145,234 | $33.0M | 4.4% | TRIM -48.9% |
Recent position changes
| Fund | Action | Prev | Current | Change | Value |
|---|---|---|---|---|---|
| BRANDES INVESTMENT PARTNERS, LP | ADD | 1,342,198 | 2,148,731 | +60.1% | $61.9M |
| DIMENSIONAL FUND ADVISORS LP | ADD | 1,052,747 | 1,837,261 | +74.5% | $53.1M |
| CAUSEWAY CAPITAL MANAGEMENT LLC | ADD | 953,146 | 1,565,167 | +64.2% | $45.1M |
| WELLS FARGO & COMPANY/MN | DOUBLED | 517,651 | 1,375,531 | +165.7% | $39.6M |
| BANK OF MONTREAL /CAN/ | TRIM | 2,243,019 | 1,145,234 | -48.9% | $33.0M |
| BANK OF AMERICA CORP /DE/ | TRIM | 1,240,440 | 653,939 | -47.3% | $18.8M |
| MILLENNIUM MANAGEMENT LLC | DOUBLED | 20,740 | 620,524 | +2891.9% | $17.9M |
| ENVESTNET ASSET MANAGEMENT INC | ADD | 463,472 | 603,230 | +30.2% | $17.4M |
| D. E. Shaw & Co., Inc. | TRIM | 911,727 | 542,865 | -40.5% | $15.6M |
| Connor, Clark & Lunn Investment Management Ltd. | NEW | — | 487,774 | — | $14.1M |
Short interest & halts
FINRA semi-monthly short positions, Reg SHO threshold status, and recent trading halts for SNN.
Shares short
4,832,632
Settlement Sep 15, 2026
Change vs prior
-22.6%
Semi-monthly cycle
Days to cover
2.2
At avg daily volume
Of shares outstanding
≈1.1%
Estimate — not % of float
All SNN filing & press-release reports (30)
- 6-K reportSep 16, 2026
- 6-K reportSep 16, 2026
- 6-K reportSep 11, 2026
- 6-K reportSep 10, 2026
- 6-K reportSep 10, 2026
- 424B5 reportSep 9, 2026
- 6-K reportSep 9, 2026
- 6-K reportSep 2, 2026
- 6-K reportSep 2, 2026
- 6-K reportSep 1, 2026
- 6-K reportAug 21, 2026
- 6-K reportAug 19, 2026
- 6-K reportAug 18, 2026
- 6-K reportAug 14, 2026
- 6-K reportAug 12, 2026
- 6-K reportAug 12, 2026
- 6-K reportAug 4, 2026
- 6-K reportAug 4, 2026
- 6-K reportAug 3, 2026
- PRESS-RELEASE reportJul 29, 2026
- 6-K reportJul 27, 2026
- 6-K reportJul 23, 2026
- 6-K reportJul 22, 2026
- 6-K reportJul 21, 2026
- PRESS-RELEASE reportJul 9, 2026
- PRESS-RELEASE reportJul 9, 2026
- 6-K reportJul 3, 2026
- 6-K reportJun 30, 2026
- PRESS-RELEASE reportJun 1, 2026
- PRESS-RELEASE reportMar 2, 2026